SciNeuro Pharmaceuticals
Rockville, United States · Founded 2020
- Headquarters
- Rockville
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
About
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company founded in late 2020 that develops novel therapeutics for neurological and neurodegenerative CNS diseases, including Alzheimer's and Parkinson's disease. Its pipeline includes antibody and antisense oligonucleotide programs targeting LRRK2, progranulin, amyloid-beta, and alpha-synuclein, alongside a proprietary blood-brain-barrier shuttle platform for CNS drug delivery. SciNeuro has partnered with organizations including the Michael J. Fox Foundation and struck a licensing and collaboration deal with Novartis worth up to $1.7 billion.
Summary
SciNeuro Pharmaceuticals is a Biotech company based in Rockville, United States, founded in 2020.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...